前列腺癌主动监测的前瞻性验证：PRIAS研究 - Suppr

Suppr

超能文献

Prospective validation of active surveillance in prostate cancer: the PRIAS study.

作者信息

van den Bergh Roderick C N, Roemeling Stijn, Roobol Monique J, Roobol Wouter, Schröder Fritz H, Bangma Chris H

出版信息

Eur Urol. 2007 Dec;52(6):1560-3. doi: 10.1016/j.eururo.2007.05.011. Epub 2007 May 25.

DOI:10.1016/j.eururo.2007.05.011

PMID:17532115

Abstract

摘要

相似文献

Prospective validation of active surveillance in prostate cancer: the PRIAS study.前列腺癌主动监测的前瞻性验证：PRIAS研究

Eur Urol. 2007 Dec;52(6):1560-3. doi: 10.1016/j.eururo.2007.05.011. Epub 2007 May 25.

Prostate cancer screening: is it possible to explain diametrically opposed views?

N Z Med J. 2005 Feb 11;118(1209):U1289.

Re: prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial: R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, f. Denardi and L. O. Reis J Urol 2010; 183: 940-945.回复：前列腺特异性抗原降低与前列腺癌诊断：抗生素与安慰剂前瞻性随机临床试验：R.M. 斯托皮利亚、U. 费雷拉、M.M. 席尔瓦、W.E. 马修斯、F. 德纳尔迪和L.O. 雷伊斯《泌尿外科杂志》2010年；183卷：940 - 945页

J Urol. 2010 Nov;184(5):2214-5; author reply 2215. doi: 10.1016/j.juro.2010.06.128. Epub 2010 Sep 22.

Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).关于《前列腺特异性抗原速度在前列腺癌筛查中对临床显著前列腺癌是否具有选择性？欧洲前列腺癌筛查随机研究（鹿特丹研究）》的社论评论

Eur Urol. 2009 Feb;55(2):392; discussion 393. doi: 10.1016/j.eururo.2008.02.047. Epub 2008 Mar 11.

Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.关于前列腺特异性抗原筛查的争议已从死亡率问题转向过度治疗问题。

Int J Urol. 2009 Sep;16(9):711-12.

Screening for prostate cancer with serum prostate-specific antigen : what should we recommend while waiting for randomized clinical trial results?使用血清前列腺特异性抗原筛查前列腺癌：在等待随机临床试验结果期间我们应推荐什么？

Cancer. 2008 Dec 1;113(11):3067-8. doi: 10.1002/cncr.23933.

Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.前列腺特异性抗原（PSA）衍生物在前列腺癌筛查和风险分层中的局限性及应用

Urol Oncol. 2009 Nov-Dec;27(6):583-4. doi: 10.1016/j.urolonc.2009.06.011.

Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.

Eur Urol. 2009 Jun;55(6):1331. doi: 10.1016/j.eururo.2009.02.030. Epub 2009 Mar 6.

Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.

Eur Urol. 2009 Jun;55(6):1331-2. doi: 10.1016/j.eururo.2009.02.029. Epub 2009 Mar 6.

PSA testing and DRE, TRUS scanning with sector biopsy, improved histology, curative treatments, and active surveillance for prostate cancer: a success story for men's health.前列腺特异性抗原（PSA）检测、直肠指检（DRE）、经直肠超声（TRUS）引导下的扇形活检、改良组织学、根治性治疗以及前列腺癌的主动监测：男性健康的成功案例。

N Z Med J. 2008 Dec 12;121(1287):57-68.

引用本文的文献

The evolving landscape: magnetic resonance imaging in active surveillance for prostate cancer management.不断演变的局面：磁共振成像在前列腺癌管理主动监测中的应用

Front Urol. 2024 Apr 12;4:1329274. doi: 10.3389/fruro.2024.1329274. eCollection 2024.

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.1级前列腺癌主动监测的长期结果以及MRI使用对过度治疗的影响。

BJU Int. 2025 Aug;136(2):245-253. doi: 10.1111/bju.16727. Epub 2025 Apr 14.

Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance.前列腺癌患者主动监测期间活检时机的个性化动态预测模型

JAMA Netw Open. 2025 Jan 2;8(1):e2454366. doi: 10.1001/jamanetworkopen.2024.54366.

Development and Validation of a Deep Learning Model Based on MRI and Clinical Characteristics to Predict Risk of Prostate Cancer Progression.基于MRI和临床特征的深度学习模型用于预测前列腺癌进展风险的开发与验证

Radiol Imaging Cancer. 2025 Jan;7(1):e240078. doi: 10.1148/rycan.240078.

Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).常规护理中对中危前列腺癌进行主动监测的治疗——一项前瞻性非干预性研究（HAROW）的长期结果

Curr Urol. 2024 Jun;18(2):115-121. doi: 10.1097/CU9.0000000000000203. Epub 2024 Jun 21.

Transperineal Laser Ablation for Focal Therapy of Localized Prostate Cancer: 12-Month Follow-up Outcomes from a Single Prospective Cohort Study.经会阴激光消融术用于局限性前列腺癌的聚焦治疗：一项单前瞻性队列研究的12个月随访结果

Cancers (Basel). 2024 Jul 23;16(15):2620. doi: 10.3390/cancers16152620.

Longitudinal evaluation of MRI findings, including quantitative apparent diffusion coefficient values, might be necessary to predict disease progression in patients with prostate cancer on active surveillance.对磁共振成像（MRI）结果进行纵向评估，包括定量表观扩散系数值，对于预测接受主动监测的前列腺癌患者的疾病进展可能是必要的。

World J Urol. 2024 Mar 26;42(1):191. doi: 10.1007/s00345-024-04932-3.

Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive Factors.对台湾局限性前列腺癌男性患者的主动监测：中期结果及预测因素

World J Mens Health. 2024 Jul;42(3):587-599. doi: 10.5534/wjmh.230107. Epub 2023 Sep 26.

Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program.靶向活检、瘤周活检、随机活检及其联合应用在主动监测方案中经直肠超声融合前列腺磁共振成像引导下确认性活检中检测临床显著前列腺癌的作用。

Prostate Cancer Prostatic Dis. 2024 Mar;27(1):129-135. doi: 10.1038/s41391-023-00733-8. Epub 2023 Oct 12.

Changing nationwide trends away from overtreatment among patients undergoing radical prostatectomy over the past 25 years.过去 25 年来，全国范围内接受根治性前列腺切除术的患者过度治疗的趋势正在发生变化。

World J Urol. 2023 Jun;41(6):1497-1502. doi: 10.1007/s00345-023-04418-8. Epub 2023 May 17.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验